Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Elixinol Wellness Limited (EXL.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.0280+0.0020 (+7.69%)
At close: 04:10PM AEST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0260
Open0.0310
Bid0.0270 x 14280600
Ask0.0280 x 19968800
Day's Range0.0280 - 0.0310
52 Week Range0.0190 - 0.1050
Volume365,670
Avg. Volume483,207
Market Cap8.855M
Beta (5Y Monthly)1.67
PE Ratio (TTM)N/A
EPS (TTM)-0.0540
Earnings DateAug 30, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for EXL.AX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      GLOBAL CBD BRAND ELIXINOL WELLNESS INTRODUCES TWO INNOVATIVE SLEEP* PRODUCTS

      Elixinol, hemp-derived CBD brand and industry veteran, announced today the launch of two new innovative CBD products focused on supporting sleep*. Elixinol's Sleep Rapid Rest Liposome and Sleep Gummies are unique, melatonin-free options for consumers to support optimal sleep. Both products include CBN, marking a first for the brand to include a minor cannabinoid into product formulations. The new product additions also coincide with the brand's new '2022 & You' wellness campaign, encouraging con

    • PR Newswire

      California's Assembly Bill 45 Formally Permits CBD Sales, Elixinol Upgrades E-commerce Capabilities and Appoints New National Sales Representation

      Elixinol Wellness Limited (Elixinol or the Company) (ASX:EXL; OTCQB:ELLXF) is pleased to communicate that Assembly Bill 45 (AB45) was signed into law by Californian Governor, Mr Gavin Newsom on 6 October 2021, establishing a comprehensive regulatory framework for the manufacture and retail sale of products in California containing hemp derived cannabidiol (CBD), including dietary supplements, topicals, over-the-counter, and pet products, among others.

    Advertisement
    Advertisement